Interpace Biosciences, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of IDXG for the last quarter is 10.27 M USD, and it's 0.10% lower compared to the previous quarter. The net income of Q1 24 is 468.00 k USD.